35 results on '"Jayne, David R W"'
Search Results
2. #3140 Investigating the impact of Anti-IL5 therapy in eosinophilic granulomatosis with polyangiitis (EGPA): a three year longitudinal perspective
3. #386 Avacopan versus prednisone taper in newly diagnosed or relapsing granulomatosis with polyangiitis or microscopic polyangiitis in the ADVOCATE trial
4. #3076 A UK parallel cohort study on renal ANCA associated vasculitis outcomes for avacopan exposed and matched unexposed cohorts
5. #3108 Rituximab in adult-onset IgA vasculitis
6. #1356 Kidney phenotype in interstitial lung disease associated with ANCA-vasculitis: European Multicentre Study
7. #1355 Albuminuria after Induction Treatment and Kidney Prognosis in ANCA-associated Glomerulonephritis
8. #464 Survey results on the utility of the Renal Risk Score and Histopathological Classification of ANCA-glomerulonephritis
9. The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseases
10. Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations
11. Challenges of defining renal response in ANCA-associated vasculitis: call to action?
12. Avacopan for ANCA-associated vasculitis – information for prescribers
13. Aggressive vasculitis after lung transplantation for cystic fibrosis
14. Eosinophilic granulomatosis with polyangiitis present and future
15. Introduction to the European Vasculitis Society 3rd International Vasculitis Course (Cambridge) case-based supplement
16. Refractory ANCA-associated vasculitis
17. A critical beat in eosinophilic granulomatosis with polyangiitis
18. Therapeutic dilemmas in relapsing renal ANCA-associated vasculitis
19. Cardiac decompensation revealing giant cell arteritis
20. COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab
21. Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study
22. IgA vasculitis (Henoch–Schönlein purpura): refractory and relapsing disease course in the adult population
23. Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
24. Introduction to the European Vasculitis Society 3rd International Vasculitis course (Cambridge, 23–25 September 2019) supplement
25. Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines
26. Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines—Executive summary
27. Estimating the epidemiology of anti-neutrophil cytoplasm antibody-associated renal vasculitis and the role of histologic chronicity in predicting renal outcomes
28. Nasal carriage of Staphylococcus pseudintermedius in patients with granulomatosis with polyangiitis
29. Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome
30. Comment on: Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature
31. Successful outcome using bortezomib in adult refractory IgA vasculitis: a case report
32. Opponent's comments
33. Con: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?
34. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
35. Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.